Does stent-based delivery of sirolimus reduce neointimal formation in a porcine coronary model?
Stent-based delivery of sirolimus via a nonerodable polymer matrix is feasible and effectively reduces neointimal hyperplasia in a preclinical porcine model.
Stent-based delivery of SRL via a nonerodable polymer matrix is feasible and effectively reduces in-stent neointimal hyperplasia by inhibiting cellular proliferation.
Suzuki et al. (Tue,) studied this question.